Literature DB >> 7670749

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

H N Hodis1, W J Mack.   

Abstract

A growing body of evidence from serial coronary angiographic studies indicates that triglyceride-rich lipoproteins are an important factor in the progression of coronary artery disease. Compelling evidence also suggests that triglyceride-rich lipoproteins may be most important in the progression of mild-moderate lesions, the very lesions that are likely to be responsible for clinical coronary events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670749     DOI: 10.1097/00041433-199508000-00004

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  11 in total

Review 1.  Impact of dyslipidaemia. Lessons from clinical trials.

Authors:  W V Brown
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

3.  Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients.

Authors:  Sirirat Likanonsakul; Tippawan Rattanatham; Siriluk Feangvad; Sumonmal Uttayamakul; Wisit Prasithsirikul; Somkid Srisopha; Ravee Nitiyanontakij; Pimrapat Tengtrakulcharoen; Maciej Tarkowski; Agostino Riva; Emi E Nakayama; Tatsuo Shioda
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-20       Impact factor: 2.205

4.  Long term effects of ketogenic diet in obese subjects with high cholesterol level.

Authors:  Hussein M Dashti; Naji S Al-Zaid; Thazhumpal C Mathew; Mahdi Al-Mousawi; Hussain Talib; Sami K Asfar; Abdulla I Behbahani
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

Review 5.  How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Authors:  Francine K Welty
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 6.  Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Authors:  D C Chan; J Pang; G Romic; G F Watts
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 7.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 8.  Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.

Authors:  Paul D Rosenblit
Journal:  Curr Diab Rep       Date:  2019-11-21       Impact factor: 4.810

9.  Evaluation of the Possible Mechanisms of Antihypertensive Activity of Loranthus micranthus: An African Mistletoe.

Authors:  Bamidele A Iwalokun; Sedoten A Hodonu; Stella Nwoke; Olabisi Ojo; Phillip U Agomo
Journal:  Biochem Res Int       Date:  2011-09-12

10.  Effects of Lagenaria sicessaria fruit juice on lipid profile and glycoprotein contents in cardiotoxicity induced by isoproterenol in rats.

Authors:  Aman Upaganlawar; R Balaraman
Journal:  Toxicol Int       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.